Drug Trial Radar · NCT05284747
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
6,019
Actual
Start
Oct 26, 2022
Primary completion
May 29, 2027
Study completion May 29, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- Collaborators
- Colorado Prevention Center
- First posted
- Mar 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid management alone when administered in the acute setting to reduce myocardial infarction, ischemic stroke, arterial revascularization, and all-cause death in subjects hospitalized for an acute myocardial infarction (non-ST-segment elevation myocardial infarction \[NSTEMI\] and ST-segment elevation myocardial infarction \[STEMI\]).
Conditions
- Cardiovascular Disease
- Myocardial Infarction
- Stroke
- Coronary Revascularization
Interventions
EvolocumabDrug
Evolocumab will be provided as a single-dose, prefilled autoinjector pen (AI/pen) for fixed dose subcutaneous (SC) injection.
Routine Lipid ManagementDrug
Routine lipid management therapies will be administered at the discretion of the investigator per SoC.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total (first and subsequent) composite of myocardial infarction, ischemic stroke, any arterial revascularization procedure, and all-cause deathTime frame: From Baseline to End of Study (Approximately 3.5 Years)
Locations
120 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Eastern Shore Research Institute
Fairhope, Alabama
Heart Center Research LLC
Huntsville, Alabama
Northern Arizona Healthcare Corporation Cardiovascular Institute
Flagstaff, Arizona
Scottsdale Healthcare at Shea - HonorHealth
Scottsdale, Arizona
Pima Heart and Vascular Clinical Research
Tuscon, Arizona
John Muir Health and Cardiovascular Institute
Concord, California
VA Greater Los Angeles Healthcare System
Los Angeles, California
University of California Los Angeles
Los Angeles, California
University of California-Irvine
Orange, California
University of Colorado Hospital
Aurora, Colorado
Bridgeport Hospital
Bridgeport, Connecticut
Hartford Hospital
Hartford, Connecticut
Cardiology Associates of Fairfield County PC
Stamford, Connecticut
Excel Medical Clinical Trials
Boca Raton, Florida
Clearwater Cardiovascular Consultants
Clearwater, Florida
University of Florida at Gainesville
Gainesville, Florida
University of Florida and Shands Hospital
Jacksonville, Florida
AdventHealth Orlando
Orlando, Florida
Cardiology Partners Clinical Research Institute
Palm Beach Gardens, Florida
Baptist Health Care
Pensacola, Florida
Ascension Sacred Heart
Pensacola, Florida
Clearwater Cardiovascular Consultants
Safety Harbor, Florida
Tampa Cardiovascular Interventions and Research
Tampa, Florida
Clinical Site Partners Orlando dba Flourish Research
Winter Park, Florida
Saint Lukes Boise Medical Center
Boise, Idaho
Jesse Brown Veterans Affairs Medical Center
Chicago, Illinois
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois
Advocate Lutheran General Hospital
Park Ridge, Illinois
Ascension Saint Vincent Heart Center
Indianapolis, Indiana
Reid Physician Associates
Richmond, Indiana
University of Kansas Hospital
Kansas City, Kansas
Midwest Heart and Vascular Specialists
Overland Park, Kansas
University of Louisville Health - Jewish Hospital
Louisville, Kentucky
Massachusetts General Hospital
Boston, Massachusetts
Henry Ford Hospital
Detroit, Michigan
Healthy Heart Cardiology
Grand Rapids, Michigan
Sparrow Clinical Research Institute
Lansing, Michigan
McLaren Macomb Research Services
Mount Clemens, Michigan
McLaren Northern Michigan Hospital
Petoskey, Michigan
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.